Could Weight-Loss Jabs be Behind Rising Gallbladder Removals?

Doctors in the UK are calling for more research into whether weight-loss injections such as Wegovy, Mounjaro, and Saxenda may be contributing to a rise in gallbladder removals. Figures show that more than 80,000 gallbladder operations were carried out in England in 2024-25, a 15 percent increase on the previous year and the highest level in a decade. Surgeons report seeing more patients who have used weight-loss jabs, but say it is unclear whether the drugs themselves directly cause gallstones or whether rapid weight loss triggered by the injections is responsible.

While the injections are being pushed as the ultimate fix for obesity, they are already known to come with a slew of other unpleasant side effects that no one’s talking about loudly enough. Nausea, vomiting, diarrhea, constipation, and abdominal pain are particularly common. More serious risks include eye damage and pancreas problems. And if patients stop having the injections, most or all of the weight they have lost will likely come back. At a cost of around US$1,000 per month per patient, the pharma industry has a vested interest in people becoming dependent on these treatments.

To learn the truth about the weight-loss industry, see this article by Dr. Aleksandra Niedzwiecki on our website.